© Copyright - Newspaper WordPress Theme by TagDiv
Budesonide
Also known as / Synonyms: Budesonide
Daily anti-inflammatory inhaler to prevent asthma attacks and reduce airway swelling.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
Maintenance treatment of asthma as prophylactic therapy; management of active Crohn's disease and ulcerative colitis (oral formulations).
Contraindications (Do Not Use If…)
Primary treatment of status asthmaticus or acute episodes of asthma requiring intensive measures; hypersensitivity to budesonide.
Important Clinical Precautions & Warnings
Rinse mouth with water without swallowing after inhalation to prevent oral candidiasis (thrush). Not for acute bronchospasm relief. Monitor growth in pediatric patients.
Special Populations (Paediatric & Geriatric Care)
Respules approved for children 12 months and older; monitor pediatric growth during prolonged therapy.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Oral candidiasis (thrush), hoarseness (dysphonia), cough, throat irritation, and headache.
Serious Side Effects — Seek Urgent Medical Care
Paradoxical bronchospasm, secondary hypocortisolism, reduced bone mineral density with long-term high doses, and glaucoma/cataracts.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir) significantly increase systemic budesonide exposure.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Inhaled budesonide is widely studied and the preferred inhaled corticosteroid during pregnancy for asthma maintenance.
Lactation & Breastfeeding:
Excreted in breast milk in minimal amounts; considered compatible with breastfeeding.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store upright below 30°C. Protect from freezing and direct sunlight.
⏱️ Missed Dose Protocol:
Take as soon as remembered. Do not double doses. Use daily for consistent anti-inflammatory control.
Acute inhalation overdose is unlikely to produce systemic toxicity. Chronic excessive doses may cause systemic corticosteroid hypercorticism.
Clinical Sources & Regulatory References
Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.
Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:
Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).
CDSCO Official Portal →U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.
Search FDA Labels on DailyMed →WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).
WHO Essential Medicines Registry →National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.
Query PubMed Studies for Budesonide →
4mg Clinical Pharmacology Team. Budesonide Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/budesonide/
